Riverain Technologies

What is Riverain Technologies?

Riverain Technologies develops ClearRead, a suite of FDA-cleared chest imaging AI. The ClearRead Chest AI suite helps radiologists detect, characterize and visualize pulmonary nodules, pneumothoraces and coronary artery calcification. It covers both chest X-ray and CT, with products such as ClearRead CT and ClearRead Xray Confirm.

Key capabilities of Riverain Technologies

• Lung nodule detection: finds and characterizes pulmonary nodules on chest CT.
• Pneumothorax detection: flags pneumothoraces on chest imaging.
• Coronary artery calcification: visualizes calcification on chest scans.
• ClearRead CT: a CT product with visualization designed to help radiologists read faster.
• ClearRead Xray Confirm: a chest X-ray product with an enhanced version.
• Platform distribution: available through the RapidAI Rapid Enterprise Platform.

How Riverain Technologies works

ClearRead runs on chest images from the radiology workflow and presents results to the radiologist for review. In October 2026 Riverain announced availability through RapidAI's platform, which RapidAI says reaches an installed base of more than 2,500 hospitals. Riverain also reports a Veterans Health Administration contract for lung nodule detection.

Who uses Riverain Technologies?

Riverain serves radiologists and hospital imaging departments, including health systems such as Cedars-Sinai, which has deployed ClearRead CT. It also has regulatory approvals outside the United States, including TGA approval in Australia.

Riverain Technologies pricing

Riverain does not publish pricing. Pricing is available from the vendor or through distribution partners.

Riverain Technologies alternatives

Aidoc provides AI triage across acute findings in many body regions and is sold as a broad imaging AI platform. Brainomix focuses on stroke and lung imaging AI, with a strong position in neurovascular care. Riverain is a specialist in chest X-ray and CT, with a focus on helping radiologists see nodules.